Innovis Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.13M Sell
5,622
-175
-3% -$34.8K 0.43% 41
2023
Q2
$1.07M Sell
5,797
-184
-3% -$34K 0.4% 44
2023
Q1
$1.15M Hold
5,981
– – 0.46% 45
2022
Q4
$1.01M Buy
+5,981
New +$1.04M 0.45% 40

Other funds holding CME

Innovis Asset Management's CME Position: Q3 2023 in Review

Innovis Asset Management reduced its CME Group (CME) stake by 3% in Q3 2023, selling an estimated $34.8K and leaving 5,622 shares worth $1.13M. The position accounts for 0.43% of the portfolio, ranked #41.

Innovis Asset Management first reported a position in CME in Q4 2022 and has held it in 4 quarters since. The position peaked at $1.15M in Q1 2023. 1,230 funds tracked by Wall St. Rank hold CME as of Q3 2023.

  • Innovis Asset Management held 5,622 shares of CME Group worth $1.13M as of Q3 2023.
  • Innovis Asset Management sold 175 CME Group shares in Q3 2023, an estimated $34.8K.
  • CME Group made up 0.43% of Innovis Asset Management's portfolio in Q3 2023, its #41 holding.
  • Innovis Asset Management first reported a position in CME Group in Q4 2022 and has held it in 4 quarters since.
  • Innovis Asset Management's CME Group position peaked at $1.15M in Q1 2023.
  • 1,230 funds tracked by Wall St. Rank held CME Group as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.